LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Vojo Vukovic, M.D., Ph.D. has been appointed Senior Vice President and Chief Medical Officer, Synta Pharmaceuticals. Prior to his appointment, Dr. Vukovic was Vice President, Clinical Research at Synta, a position he has held since January 2009. Eric Jacobson, M.D., recently announced his resignation as Senior Vice President and Chief Medical Officer, and will be leaving Synta after a brief transition period.
